Research

CJC-1295 with DAC vs CJC-1295 No DAC: How the Research Compares Both forms of CJC-1295 are synthetic analogs of growth-hormone-releasing hormone built on a modified GRF(1-29) sequence; the key research distinction is the Drug Affinity Complex (DAC) and its effect on half-life. At a glance Property CJC-1295 with DAC CJC-1295 No DAC Class GHRH(1-29) analog […]

Tesamorelin vs Ipamorelin: How the Research Compares Tesamorelin and Ipamorelin are both studied in growth-hormone-axis research, but they act on two different arms of GH release: the GHRH receptor and the growth-hormone-secretagogue receptor. At a glance Property Tesamorelin Ipamorelin Class Stabilized GHRH analog Selective GH secretagogue (peptide) Primary research target GHRH receptor GHS-R1a (ghrelin receptor) […]

MOTS-c vs 5-Amino-1MQ: How the Research Compares MOTS-c and 5-Amino-1MQ are both studied in metabolic research, but one is a mitochondrial-derived peptide and the other a small-molecule enzyme inhibitor with distinct targets. At a glance Property MOTS-c 5-Amino-1MQ Class Mitochondrial-derived peptide Small-molecule NNMT inhibitor Primary research target AMPK / metabolic homeostasis NNMT enzyme Research domain […]

BPC-157 vs GHK-Cu: How the Research Compares BPC-157 and GHK-Cu both appear across tissue-repair research, but one is a pentadecapeptide studied in angiogenesis and connective-tissue models and the other a copper tripeptide studied in dermal and extracellular-matrix models. At a glance Property BPC-157 GHK-Cu Class Synthetic pentadecapeptide Copper tripeptide (Gly-His-Lys-Cu) Primary research target NO / […]

Kisspeptin vs HCG: How the Research Compares Kisspeptin and HCG both appear in reproductive-endocrinology research, but they act at opposite ends of the hypothalamic-pituitary-gonadal axis: upstream signaling versus a downstream gonadal receptor. At a glance Property Kisspeptin HCG Class Synthetic peptide (Kisspeptin-10) Glycoprotein hormone Primary research target KISS1R (upstream of GnRH) LH/CG receptor (gonadal) Research […]

PT-141 vs MT-2 (Melanotan 2): How the Research Compares PT-141 (bremelanotide) and MT-2 (Melanotan II) are both synthetic cyclic heptapeptides studied as melanocortin-receptor agonists, but research interest centers on different receptor subtypes. At a glance Property PT-141 MT-2 (Melanotan 2) Class Synthetic cyclic heptapeptide Synthetic cyclic heptapeptide Primary research target MC3R / MC4R (central) MC1R […]

GLOW Complex: What the Research Shows GLOW Complex is a combination research blend of three peptides (GHK-Cu, BPC-157, and TB-500) supplied at a 50:10:10 ratio (70 mg total). It is studied across tissue-repair, dermal extracellular-matrix, and angiogenesis research models. As a multi-component blend, GLOW Complex is a research preparation rather than a single molecular entity. […]

CJC-1295 (with DAC): What the Research Shows CJC-1295 with DAC is a synthetic, long-acting analog of growth-hormone-releasing hormone (GHRH), built on a modified GRF(1-29) sequence and incorporating Drug Affinity Complex (DAC) technology that extends its research half-life. It is studied in preclinical research within the somatotropic axis and neuroendocrine signaling. In this modified form it […]

HCG: What the Research Shows HCG (human chorionic gonadotropin) is a glycoprotein hormone studied in preclinical research within reproductive-endocrinology and gonadal-signaling models. Unlike small synthetic peptides, HCG is a heterodimeric glycoprotein composed of an alpha and a beta subunit, supplied as a lyophilized research material. As a glycoprotein hormone, HCG is characterized in research models […]

MT-2 (Melanotan II): What the Research Shows MT-2, or Melanotan II, is a synthetic cyclic heptapeptide and a melanocortin-receptor agonist. It is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH), studied in preclinical research within melanogenesis and pigmentation models. MT-2 does not occur as a discrete protein in the human proteome, which makes it a fully […]